American Portfolios Advisors Amgen Inc Transaction History

American Portfolios Advisors

$2.36 Trillion
Q3 2022

A detailed history of American Portfolios Advisors transactions in Amgen Inc stock. As of the latest transaction made, American Portfolios Advisors holds 13,887 shares of AMGN stock, worth $4.09 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

13,887

Holding current value

$4.09 Million

% of portfolio

0.13%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Mar 17, 2023	BUY	$224.46 - $253.15 $3.12 Million - $3.52 Million	13,887 New	13,887 $3.13 Billion
Q2 2022 Mar 20, 2023	SELL	$230.71 - $256.74 $964,598 - $1.07 Million	-4,181 Reduced 30.11%	9,706 $2.36 Billion
Q1 2022 Mar 21, 2023	SELL	$219.27 - $242.57 $747,491 - $826,921	-3,409 Reduced 24.55%	10,478 $2.53 Billion
Q4 2021 Mar 21, 2023	SELL	$198.88 - $227.6 $1.12 Million - $1.28 Million	-5,637 Reduced 40.59%	8,250 $1.86 Billion
Q3 2021 Mar 22, 2023	SELL	$212.27 - $248.7 $1.29 Million - $1.51 Million	-6,056 Reduced 43.61%	7,831 $1.67 Billion
Q2 2021 Mar 22, 2023	SELL	$233.58 - $259.14 $1.49 Million - $1.65 Million	-6,385 Reduced 45.98%	7,502 $1.83 Billion
Q1 2021 Mar 22, 2023	SELL	$221.91 - $258.6 $1.6 Million - $1.86 Million	-7,198 Reduced 51.83%	6,689 $1.66 Billion
Q4 2020 Mar 22, 2023	SELL	$216.38 - $257.67 $1.77 Million - $2.11 Million	-8,183 Reduced 58.93%	5,704 $1.31 Billion
Q3 2020 Mar 22, 2023	SELL	$234.65 - $260.95 $1.88 Million - $2.09 Million	-8,001 Reduced 57.62%	5,886 $1.5 Billion
Q2 2020 Mar 24, 2023	BUY	$197.81 - $242.74 $1,978 - $2,427	10 Added 0.16%	6,134 $1.45 Billion
Q1 2020 Mar 24, 2023	SELL	$182.24 - $241.7 $1.41 Million - $1.88 Million	-7,763 Reduced 55.9%	6,124 $1.24 Billion
Q4 2019 Mar 24, 2023	SELL	$189.21 - $243.2 $1.39 Million - $1.78 Million	-7,337 Reduced 52.83%	6,550 $1.58 Billion
Q3 2019 Mar 24, 2023	SELL	$174.11 - $208.62 $5,919 - $7,093	-34 Reduced 0.48%	7,029 $1.36 Billion
Q2 2019 Mar 24, 2023	SELL	$166.7 - $195.41 $1.14 Million - $1.33 Million	-6,824 Reduced 49.14%	7,063 $1.3 Billion
Q1 2019 Mar 24, 2023	BUY	$180.87 - $203.88 $196,243 - $221,209	1,085 Added 21.23%	6,196 $1.18 Billion
Q4 2018 Mar 24, 2023	SELL	$178.4 - $208.25 $83,134 - $97,044	-466 Reduced 8.36%	5,111 $995 Million
Q3 2018 Mar 24, 2023	SELL	$185.29 - $208.89 $1.54 Million - $1.74 Million	-8,310 Reduced 59.84%	5,577 $1.16 Billion
Q2 2018 Mar 24, 2023	BUY	$166.05 - $186.51 $37,693 - $42,337	227 Added 4.21%	5,613 $1.04 Billion
Q1 2018 Mar 24, 2023	SELL	$169.43 - $198.0 $1.44 Million - $1.68 Million	-8,501 Reduced 61.22%	5,386 $918 Million
Q4 2017 Mar 24, 2023	SELL	$168.79 - $188.59 $1.76 Million - $1.96 Million	-10,418	3,469 $603 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Account

American Portfolios Advisors Amgen Inc Transaction History